These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9712438)

  • 1. Numeric aberration of chromosome 17 is strongly correlated with p53 overexpression, tumor proliferation and histopathology in human bladder cancer.
    Li B; Kanamaru H; Noriki S; Fukuda M; Okada K
    Int J Urol; 1998 Jul; 5(4):317-23. PubMed ID: 9712438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer.
    Waldman FM; Carroll PR; Kerschmann R; Cohen MB; Field FG; Mayall BH
    Cancer Res; 1991 Jul; 51(14):3807-13. PubMed ID: 1676611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage.
    Skopelitou A; Hadjiyannakis M; Dimopoulos D; Kamina S; Krikoni O; Alexopoulou V; Rigas C; Agnantis NJ
    Eur Urol; 1997; 31(4):464-71. PubMed ID: 9187909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Numerical chromosome aberrations in bladder cancer detected by in situ hybridization.
    Nemoto R; Nakamura I; Uchida K; Harada M
    Br J Urol; 1995 Apr; 75(4):470-6. PubMed ID: 7788258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
    Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
    Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
    Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCNA and p53 in urinary bladder cancer: correlation with histological findings and prognosis.
    Inagaki T; Ebisuno S; Uekado Y; Hirano A; Hiroi A; Shinka T; Ohkawa T
    Int J Urol; 1997 Mar; 4(2):172-7. PubMed ID: 9179692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.
    Hopman AH; van Hooren E; van de Kaa CA; Vooijs PG; Ramaekers FC
    Mod Pathol; 1991 Jul; 4(4):503-13. PubMed ID: 1924281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7.
    Amare Kadam PS; Varghese C; Bharde SH; Narasimhamoorthy NK; Desai S; Advani SH; Havaldar R; Kulkarni JN
    Cancer Genet Cytogenet; 2001 Mar; 125(2):139-46. PubMed ID: 11369057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ki-67 fraction, p53 alteration and numerical chromosome aberrations (chromosomes 7 and 17) in formalin fixed bladder tumors].
    Moch H; Sauter G; Gudat F; Waldman F; Mihatsch MJ
    Verh Dtsch Ges Pathol; 1993; 77():226-30. PubMed ID: 7511286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
    Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
    Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.
    Krüger S; Mess F; Böhle A; Feller AC
    Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal aberrations in transitional cell carcinoma: its correlation with tumor behavior.
    Yu DS; Chen HI; Chang SY
    Urol Int; 2002; 69(2):129-35. PubMed ID: 12187044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer.
    Sauter G; Moch H; Gasser TC; Mihatsch MJ; Waldman FM
    Cytometry; 1995 Sep; 21(1):40-6. PubMed ID: 8529469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationships among DNA ploidy type determined by laser scanning cytometry, the overexpression of p53 protein and the numerical aberrations of chromosome 7 in bladder cancer].
    Kawamura K; Ikeda R; Suzuki K
    Hinyokika Kiyo; 2000 Jun; 46(6):377-83. PubMed ID: 10934605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization.
    Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H
    Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.
    Nakopoulou L; Vourlakou C; Zervas A; Tzonou A; Gakiopoulou H; Dimopoulos MA
    Hum Pathol; 1998 Feb; 29(2):146-54. PubMed ID: 9490274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of genetic instability with immunoreactivities for p53 protein and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Yagi H; Urakami S; Shirakawa H; Ishibe T
    Eur Urol; 1996; 30(1):80-8. PubMed ID: 8854073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.